Accessibility Statement

We are committed to providing a website that is accessible to the widest possible audience. To do so, we are actively working with consultants to update the website by increasing its accessibility and usability by persons who use assistive technologies such as automated tools, keyboard-only navigation, and screen readers.

We are working to have the website conform to the relevant standards of the Section 508 Web Accessibility Standards developed by the United States Access Board, as well as the World Wide Web Consortium's (W3C) Web Content Accessibility Guidelines 2.1. These standards and guidelines explain how to make web content more accessible for people with disabilities. We believe that conformance with these standards and guidelines will help make the website more user friendly for all people.

Our efforts are ongoing. While we strive to have the website adhere to these guidelines and standards, it is not always possible to do so in all areas of the website. If, at any time, you have specific questions or concerns about the accessibility of any particular webpage, please contact WebsiteAccess@tenethealth.com so that we may be of assistance.

Thank you. We hope you enjoy using our website.

Skip to Main Content

Neurological Institute opens study of brain aneurysm stent

Aug 4, 2020

TUCSON – Carondelet St. Joseph’s Hospital is now participating in a clinical trial to evaluate the safety and effectiveness of a new stent used to treat brain aneurysms, which can lead to hemorrhagic stroke. The new study opened in July, and St. Joseph’s Hospital is one of a select number of sites to participate in the trial in the U.S.

evolve-clinic-2-300x200-news-release

The research study will collect data on the use of a new stent designed to treat patients 18 years or older with brain aneurysms.

evolve-clinic-300x200-news-releasePhysicians at the Carondelet Neurological Institute at St. Joseph’s Hospital will evaluate the Surpass Evolve Flow Diverter System in the treatment of unruptured, wide-neck intracranial aneurysms located on the internal carotid artery or its branches. Flow diverters will help physicians to treat their patients suffering from brain aneurysms without entering the sac of the aneurysm itself.

“Our intent is to not only provide the highest level of care to the patients we serve here in Tucson, but to demonstrate leadership in the trial and share the learnings from our experience all over the world,” said Dr. Alexander Coon, Carondelet’s director of endovascular and cerebrovascular neurosurgery.

The FDA trial is set to be the one of largest prospective cerebral aneurysm stent trials to date, according to Dr. Coon. The study is taking place at only 40 sites in the United States, Canada and Australia.

“Through the years, our Carondelet Neurological Institute has committed to clinical excellence, innovation, research, education and outstanding patient care,” said St. Joseph’s Hospital Chief Operating Officer Dr. Nikki Castel. “We are proud of the entire Neurological Institute for bringing new, life saving technology to our community.”

St. Joseph’s Hospital is a primary stroke center and site of the Carondelet Neurological Institute, with additional programs for brain and spine tumors, balance and vestibular disorders, rehabilitation, education and support. The hospital offers advanced brain and spine care services, from diagnosis to treatment and rehabilitation, a dedicated neurological critical-care unit.

For more information on brain and spine services available through the Carondelet Neurological Institute, click here.

Sign Up for Health Tips

Get our advice and upcoming events about weight, pain, heart and more.

Find a Doctor

Need a doctor for your care?